Literature DB >> 10506697

Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection.

C M Lee1, S N Lu, C S Changchien, C T Yeh, T T Hsu, J H Tang, J H Wang, D Y Lin, C L Chen, W J Chen.   

Abstract

BACKGROUND: There are etiologic variations of hepatocellular carcinoma (HCC) in different geographic areas. Taiwan is a hyperendemic area for hepatitis B virus (HBV) infection. Hepatitis C virus (HCV) infection also plays an important role in HCC development in Taiwan. Identification of local HCV-endemic areas is important to keep HCV from spreading. This study investigated the etiologic variations of HCC in different geographic areas of Taiwan.
METHODS: The authors evaluated the hepatitis B surface antigen (HBsAg) and antibodies to HCV (anti-HCV) status of 284 patients (232 male, 52 female) with HCC. They also evaluated the gender ratio and mean age of these patients.
RESULTS: The mean age of HBsAg positive patients was significantly lower than the mean age of HBsAg negative patients (52.6 +/- 12.3 vs. 61.3 +/- 11.2 years) (P < 0.05). The male-to-female ratio was 4.5:1 for all HCC patients, 7:1 for HBsAg positive HCC patients, and 2.8:1 for anti-HCV positive HCC patients. In Chaiyi County in southern Taiwan, the prevalence of anti-HCV in male HCC patients was 52%, significantly greater than that of Taiwan as a whole (27.6%) (P = 0.07). However, the prevalence of anti-HCV in male HCC patients in Taipei County in northern Taiwan was 8.7%, significantly less than that of Taiwan as a whole (P = 0.043). Of a total of 65 Chiayi-based HCC patients, 55.4% were anti-HCV positive and 46.2% were HBsAg positive. In the Chiayi area, results of multiple logistic regression showed that the HCC patients who were age 60 years or older or who were living in the city area both had highly HCV-related disease.
CONCLUSIONS: The mean age of patients with HBV-related HCC was significantly lower than that of patients with non-HBV-related HCC. The male-to-female ratio for patients with HBV-related HCC was significantly higher than that of patients with HCV-related HCC. The authors identified an area of Taiwan in which HCV-related HCC was prevalent. Copyright 1999 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10506697     DOI: 10.1002/(sici)1097-0142(19991001)86:7<1143::aid-cncr7>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  48 in total

1.  Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.

Authors:  S D Ryder
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

2.  Male-specific W4P/R mutation in the pre-S1 region of hepatitis B virus, increasing the risk of progression of liver diseases in chronic patients.

Authors:  Seoung-Ae Lee; Ki-Jeong Kim; Dong-Won Kim; Bum-Joon Kim
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

3.  Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level.

Authors:  Chi-Ming Chiu; Shiou-Hwei Yeh; Pei-Jer Chen; Ti-Jung Kuo; Ching-Ju Chang; Po-Jen Chen; Wan-Jen Yang; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-26       Impact factor: 11.205

4.  Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study.

Authors:  Hui-Chen Wu; Qiao Wang; Hwai-I Yang; Wei-Yann Tsai; Chien-Jen Chen; Regina M Santella
Journal:  Carcinogenesis       Date:  2012-05-12       Impact factor: 4.944

5.  Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.

Authors:  C Rabe; T Pilz; C Klostermann; M Berna; H H Schild; T Sauerbruch; W H Caselmann
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

6.  High risk of hepatitis B virus reactivation in nucleos(t)ide analogue-induced hepatitis B e antigen seroconverters older than 40 years.

Authors:  Li-Fu Kuo; Chuan-Mo Lee; Chao-Hung Hung; Jing-Houng Wang; Tsung-Hui Hu; Sheng-Nan Lu; Chi-Sin Changchien; Chien-Hung Chen
Journal:  Dig Dis Sci       Date:  2014-05-21       Impact factor: 3.199

7.  Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.

Authors:  Ming-Heng Wu; Wen-Lung Ma; Cheng-Lung Hsu; Yuh-Ling Chen; Jing-Hsiung James Ou; Charlotte Kathryn Ryan; Yao-Ching Hung; Shuyuan Yeh; Chawnshang Chang
Journal:  Sci Transl Med       Date:  2010-05-19       Impact factor: 17.956

8.  Activation of signal transduction pathways during hepatic oncogenesis.

Authors:  Waihong Chung; Miran Kim; Suzanne de la Monte; Lisa Longato; Rolf Carlson; Betty L Slagle; Xiaoqun Dong; Jack R Wands
Journal:  Cancer Lett       Date:  2015-10-01       Impact factor: 8.679

9.  Dual-Labeled Time-Resolved Immunofluorometric Assay for the Simultaneous Quantitative Detection of Hepatitis B Virus Antigens in Human Serum.

Authors:  Rong-Liang Liang; Yun-Sen Yang; Jian-Wei Zhou; Tian-Cai Liu; Xu-Ping Xu; Qian-Ni Liang; Zhen-Hua Chen; Zhi-Ning Dong; Ying-Song Wu
Journal:  J Fluoresc       Date:  2016-11-22       Impact factor: 2.217

10.  Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy.

Authors:  Evangelista Sagnelli; Tommaso Stroffolini; Caterina Sagnelli; Mario Pirisi; Sergio Babudieri; Guido Colloredo; Maurizio Russello; Nicola Coppola; Giovanni Battista Gaeta; Bruno Cacopardo; Massimo De Luca; Piero Luigi Almasio
Journal:  Infection       Date:  2017-11-17       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.